SouthState’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$44.1K Buy
511
+421
+468% +$37.4K ﹤0.01% 515
2026
Q2
$8.14K Buy
90
+17
+23% +$1.42K ﹤0.01% 728
2026
Q1
$5.85K Sell
73
-36
-33% -$2.97K ﹤0.01% 739
2025
Q4
$9.29K Sell
109
-10
-8% -$821 ﹤0.01% 698
2025
Q3
$9.26K Sell
119
-248
-68% -$19.4K ﹤0.01% 673
2025
Q2
$28.7K Hold
367
– – ﹤0.01% 587
2025
Q1
$26.6K Buy
+367
New +$26.3K ﹤0.01% 633
2023
Q3
– Sell
-360
Closed -$34K – 644
2023
Q2
$34K Hold
360
– – ﹤0.01% 377
2023
Q1
$29.8K Hold
360
– – ﹤0.01% 405
2022
Q4
$26.9K Sell
360
-73
-17% -$5.63K ﹤0.01% 438
2022
Q3
$36K Buy
433
+73
+20% +$7.02K ﹤0.01% 414
2022
Q2
$34K Buy
+360
New +$37.3K ﹤0.01% 446

Other funds holding EW

SouthState's EW Position: Q3 2026 in Review

SouthState increased its Edwards Lifesciences (EW) stake by 468% in Q3 2026, buying an estimated $37.4K and bringing the position to 511 shares worth $44.1K. The position accounts for ﹤0.01% of the portfolio, ranked #515.

SouthState first reported a position in EW in Q2 2022 and has held it in 12 quarters since. 1,141 funds tracked by Wall St. Rank hold EW as of Q3 2026.

  • SouthState held 511 shares of Edwards Lifesciences worth $44.1K as of Q3 2026.
  • SouthState bought 421 Edwards Lifesciences shares in Q3 2026, an estimated $37.4K.
  • Edwards Lifesciences made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #515 holding.
  • SouthState first reported a position in Edwards Lifesciences in Q2 2022 and has held it in 12 quarters since.
  • 1,141 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.